In patients with ulcerative colitis, initiation of biologic therapy within 12 months of diagnosis is linked to a lower risk for disease progression than later initiation.

For people with UC, ‘feeling better’ is just the start. Learn why tissue-level (histological) healing is becoming the new ...

Researchers have used advanced genetic sequencing on a Brisbane family to identify a gene mutation linked to ulcerative colitis, a type of inflammatory bowel condition, sparking hopes of new ...

Switching UC treatments while managing a career and home life can be a major challenge. Here’s how to navigate work logistics ...

T he goal of ulcerative colitis (UC) treatment is twofold: to heal the inflamed mucosal lining of the gut and to eliminate symptoms such as cramping and pain (usually once the inflammation subsides).

Icotyde is the first targeted oral peptide IL‑23 receptor antagonist, designed to interrupt a core psoriasis inflammatory axis while avoiding injection-based administration typical of IL‑23 biologics.

News and commentary from the world of gastroenterology and hepatology ...

On March 18, 2026, Sandoz announced a new license, development, and commercialization partnership agreement with Samsung ...

Alex Lyons has Ulcerative Colitis one of the most common forms of inflammatory bowel disease.

Imagine you and your gastroenterologist have discussed a new ulcerative colitis (UC) treatment plan that promises to reduce your symptoms and the stress that comes with them. Then, when you go to ...

Indiana University School of Medicine scientists have uncovered new evidence that an age-related blood condition may ...